Preanalytical pitfalls of blood sampling to measure true circulating matrix metalloproteinase 9 and tissue inhibitors of matrix metalloproteinases

Clinica Chimica Acta

Volumn 373, Issue 1-2, 2006, Pages 180-181

  Jung, Klaus ^a   Gerlach, Raquel F ^b   Tanus Santos, Jose E ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Blood sampling; Matrix metalloproteinsases; Preanalytical effects; Test utilization

Indexed keywords

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

BLOOD SAMPLING; CONCENTRATION (PARAMETERS); ENZYME ANALYSIS; ENZYME BLOOD LEVEL; HUMAN; LETTER; PRIORITY JOURNAL;

DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MATRIX METALLOPROTEINASE 9; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SPECIMEN HANDLING; TIME FACTORS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 33747891672     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.03.001     Document Type: Letter

References (10)

1. Jacqueminet S., Ben A.O., Chapman M.J., et al. Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy. Clin Chim Acta (2006) 10.1016/j.cca.2005.11.029
2. Jung K., Nowak L., Lein M., Henke W., Schnorr D., and Loening S.A. What kind of specimen should be selected for determining tissue inhibitor of metalloproteinase-1 (TIMP-1) in blood?. Clin Chim Acta 254 (1996) 97-100
3. Jung K., Laube C., Lein M., et al. Kind of sample as preanalytical determinant of matrix metalloproteinases 2 and 9 (MMP2; MMP9) and tissue inhibitor of metalloproteinase 2 (TIMP2) in blood. Clin Chem 44 (1998) 1060-1062
4. Makowski G.S., and Ramsby M.L. Use of citrate to minimize neutrophil matrix metalloproteinase-9 in human plasma. Anal Biochem 322 (2003) 283-286
5. Mannello F., Luchetti F., Canonico B., and Papa S. Effect of anticoagulants and cell separation media as preanalytical determinants on zymographic analysis of plasma matrix metalloproteinases. Clin Chem 49 (2003) 1956-1957
6. Souza-Tarla C.D., Uzuelli J.A., Machado A.A., Gerlach R.F., and Tanus-Santos J.E. Methodological issues affecting the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Clin Biochem 38 (2005) 410-414
7. Alby C., Ben A.O., Foglietti M.J., and Beaudeux J.L. Preanalytical aspects regarding the measurement of metalloproteinase-9 and tissue inhibitor or metalloproteinase-1 in blood. Clin Chim Acta 325 (2002) 183-186
8. Jung K., Lein M., Laube C., and Lichtinghagen R. Blood specimen collection methods influence the concentration and the diagnostic validity of matrix metalloproteinase 9 in blood. Clin Chim Acta 314 (2001) 241-244
9. Meisser A., Cohen M., and Bischof P. Concentrations of circulating gelatinases (matrix metalloproteinase-2 and -9) are dependent on the conditions of blood collection. Clin Chem 51 (2005) 274-276
10. Gerlach R.F., Uzuelli J.A., Souza-Tarla C.D., and Tanus-Santos J.E. Effect of anticoagulants on the determination of plasma matrix metalloproteinase (MMP)-2 and MMP-9 activities. Anal Biochem 344 (2005) 147-149